Open | 0.00 |
Previous Close | 0.0014 |
Day Range | 0.00 - 0.00 |
52-Week Range | 0.0014 - 0.0733 |
All-Time High | 800.00 |
Avg. Volume (50-day) | 1,090.66 |
EPS (TTM) | -1.1750 |
Next Earnings Date | - |
Last Earnings Date | - |
Forward Annual Dividend (Yield) | - |
Trailing Annual Dividend (Yield) | - |
Options | No |
P/E Ratio | - |
PEG Ratio | - |
Price to Book | - |
Price to Cash Flow | - |
Price to Free Cash Flow | - |
Total Sales (TTM) | - |
Revenue per Share (TTM) | - |
Shares Outstanding | 1.497 M |
Share Float (%) | 0.84 M |
% Held by Institutions | 0.01 |
Dividends Per Share (TTM) | - |
Ex-Dividend Date | - |
+/- EMA(20) | 0.0014 (+0.00%) |
+/- SMA(50) | 0.0014 (+0.00%) |
+/- SMA(200) | 0.0076 (-81.58%) |
5-Day Perf. | - |
1-Month Perf. | - |
3-Month Perf. | - |
6-Month Perf. | - |
YTD Perf. | - |
1-Year Perf. | - |
RSI(14) | 44.41 |
ATR(14) | - |
ADX(14) | 11.31 |
Beta (5Y) | 440.95 |
RegeneRx Biopharmaceuticals, Inc. engages in the development of a novel therapeutic peptide, Thymosin beta 4 for tissue and organ protection, repair, and regeneration. Its product pipeline includes RGN-259, RGN-352, and RGN-137. The company was founded by Allan L. Goldstein on May 13, 1982 and is headquartered in Rockville, MD.
RGRX has triggered the following predefined scans:
No Recent Scan Appearances |
As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.
As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.